↓ Skip to main content

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

Overview of attention for article published in Frontiers in immunology, May 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
Published in
Frontiers in immunology, May 2022
DOI 10.3389/fimmu.2022.859419
Pubmed ID
Authors

Maxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, Caroline Ruetsch, Daisy Graça, Vincent L. M. Esnault, Vesna Brglez, Barbara Seitz-Polski

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 16%
Other 3 12%
Student > Postgraduate 3 12%
Researcher 3 12%
Student > Master 2 8%
Other 4 16%
Unknown 6 24%
Readers by discipline Count As %
Medicine and Dentistry 13 52%
Unspecified 2 8%
Business, Management and Accounting 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 6 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2024.
All research outputs
#15,692,136
of 26,169,168 outputs
Outputs from Frontiers in immunology
#14,720
of 33,003 outputs
Outputs of similar age
#210,201
of 450,934 outputs
Outputs of similar age from Frontiers in immunology
#770
of 1,694 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 1,694 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.